Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Rapid, Non-invasive, Clinical Surveillance for CachExia, Sarcopenia, Portal Hypertension and Hepatocellular Carcinoma in End-Stage Liver Disease

NCT05502198 is registered in ClinicalTrials.gov with Linkoeping University as lead sponsor.

NCT NCT05502198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05502198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Rapid, Non-invasive, Clinical Surveillance for CachExia, Sarcopenia, Portal Hypertension and Hepatocellular Carcinoma in End-Stage Liver Disease
Lead sponsor
Linkoeping University
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2021
Completion date
June 30, 2030
Enrollment
150 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, liver cirrhosis, portal hypertension, sarcopenia